Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02339571 |
|---|---|
| Brief Title: | A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma |
| First Submitted : | January 12, 2015 |
| First Submitted that Met QC Criteria : | January 12, 2015 |
| First Posted : | January 15, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 18, 2024 |
| Last Update Posted : | May 21, 2024 (Estimate) |